Next Generation Sequencing of Hematologic Neoplasms


This presentation will provide an overview of next generation sequencing based testing in hematologic malignancies.

Originally presented on February 8, 2017 in Park City, Utah.

Lecture Presenter

Todd Kelley, MD

Todd Kelley, MD

Associate Professor of Pathology
University of Utah School of Medicine
Medical Director, Molecular Hematopathology
ARUP Laboratories

Dr. Kelley is an associate professor in the Department of Pathology at the University of Utah. He received his MS in immunology and microbiology and his MD from Ohio State University, and completed his residency in anatomic and clinical pathology and fellowship training in hematopathology at the Cleveland Clinic. He is board certified in anatomic and clinical pathology by the American Board of Pathology, with subspecialty certification in hematology. His research interests include the identification of novel diagnostic and prognostic biomarkers in leukemia and lymphoma.


After this presentation, participants will be able to:

  • List a few examples of the types of NGS tests
  • Describe the clinical utility of NGS technology in the context of testing of hematologic neoplasms

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories